Exiqon AS-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exiqon AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012883
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products. Its microRNA research products comprise RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits, and functional analysis. Exiqon offers services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service. The company’s products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection. It operates in Denmark and the US. Exiqon is headquartered in Vedbaek, Denmark.

Exiqon AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exiqon A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exiqon A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exiqon A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exiqon A/S, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exiqon A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exiqon A/S, Medical Equipment, Deal Details 10
Transgenomic Expands Licensing Agreement with Exiqon 10
Equity Offering 11
Exiqon Completes Private Placement Of Shares For US$2.6 Million 11
Debt Offering 12
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 12
Exiqon Completes Private Placement Of Bonds For US$3 Million 13
Acquisition 14
Qiagen Acquires Exiqon for up to USD102.4 Million 14
Exiqon A/S – Key Competitors 16
Exiqon A/S – Key Employees 17
Exiqon A/S – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Apr 26, 2016: Exiqon: First Quarter 2016 Supports Continued Strong Momentum 19
Feb 08, 2016: Exiqon realizes full year 2015 profitability driven by strong revenue growth 20
Corporate Communications 21
Jul 04, 2016: Exiqon – Nomination of candidates for the supervisory board 21
Legal and Regulatory 22
Jul 13, 2016: Nasdaq Copenhagen accepts Exiqon request for delisting and cancellation from trading of the Exiqon shares 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Exiqon A/S, Medical Equipment, Key Facts 2
Exiqon A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exiqon A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exiqon A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exiqon A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exiqon A/S, Deals By Market, 2011 to YTD 2017 8
Exiqon A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Transgenomic Expands Licensing Agreement with Exiqon 10
Exiqon Completes Private Placement Of Shares For US$2.6 Million 11
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 12
Exiqon Completes Private Placement Of Bonds For US$3 Million 13
Qiagen Acquires Exiqon for up to USD102.4 Million 14
Exiqon A/S, Key Competitors 16
Exiqon A/S, Key Employees 17
Exiqon A/S, Subsidiaries 18

★海外企業調査レポート[Exiqon AS-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UDG Healthcare Plc (UDG)-医療機器分野:企業M&A・提携分析
    Summary UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities …
  • Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • Swift Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Kansas City Power & Light Co:発電所・企業SWOT分析
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Spectris plc:企業の戦略・SWOT・財務情報
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Garware Polyester Ltd (500655):企業の財務・戦略的SWOT分析
    Garware Polyester Ltd (500655) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CNH Industrial NV:企業の戦略・SWOT・財務情報
    CNH Industrial NV - Strategy, SWOT and Corporate Finance Report Summary CNH Industrial NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sanlam Limited:企業の戦略・SWOT・財務情報
    Sanlam Limited - Strategy, SWOT and Corporate Finance Report Summary Sanlam Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Marubeni Corporation (8002)-石油・ガス分野:企業M&A・提携分析
    Summary Marubeni Corporation (Marubeni) is an integrated trading and investment business that operates through its domestic and overseas subsidiaries. It provides various products and commodities such as agri and marine products, chemicals, energy, metals and minerals, machinery, textiles, forest pr …
  • Canaan Partners:企業のM&A・事業提携・投資動向
    Canaan Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Canaan Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • China Mengniu Dairy Co Ltd:企業のM&A・事業提携・投資動向
    China Mengniu Dairy Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Mengniu Dairy Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Prodware SA:企業の戦略・SWOT・財務情報
    Prodware SA - Strategy, SWOT and Corporate Finance Report Summary Prodware SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Avanti Feeds Ltd (AVANTIFEED):企業の財務・戦略的SWOT分析
    Avanti Feeds Ltd (AVANTIFEED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Intertech Bilgi Islem ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Birner Dental Management Services Inc (BDMS):企業の財務・戦略的SWOT分析
    Summary Birner Dental Management Services Inc (Perfect Teeth) is a dental care service provider. The company offers dental care services such as orthodontics, pediatric dentistry, periodontics, perio protect, endodontics and oral surgery. It also offers fillings and aesthetic procedures, porcelain v …
  • Distell Group Limited:企業の戦略・SWOT・財務情報
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sierra Oncology Inc (SRRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆